6TE6

Crystal structure of Dot1L in complex with an inhibitor (compound 3).

Summary for 6TE6

Entry DOI	10.2210/pdb6te6/pdb
Descriptor	Histone-lysine N-methyltransferase, H3 lysine-79 specific, ~{N}1-[(~{S})-(3-chlorophenyl)-pyridin-2-yl-methyl]-4-methylsulfonyl-~{N}2-pyrimidin-2-yl-benzene-1,2-diamine (3 entities in total)
Functional Keywords	dot1l, complex structure, inhibitor, transferase
Biological source	Homo sapiens (Human)
Total number of polymer chains	2
Total formula weight	77845.10
Authors	Scheufler, C.,Stauffer, F.,Be, C.,Moebitz, H. (deposition date: 2019-11-11, release date: 2019-12-11, Last modification date: 2024-01-24)
Primary citation	Stauffer, F.,Weiss, A.,Scheufler, C.,Mobitz, H.,Ragot, C.,Beyer, K.S.,Calkins, K.,Guthy, D.,Kiffe, M.,Van Eerdenbrugh, B.,Tiedt, R.,Gaul, C. New Potent DOT1L Inhibitors forin VivoEvaluation in Mouse. Acs Med.Chem.Lett., 10:1655-1660, 2019 Cited by PubMed: 31857842 DOI: 10.1021/acsmedchemlett.9b00452 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.98 Å)

Structure validation